News

What do we know about pharmacy-based take-home naloxone programs?

Check out our recent scoping review:https://doi.org/10.3390/pharmacy9010030

Who should receive a naloxone kit?Answer: Anyoneusing opioids or at risk of opioid-induced respiratory depression.

Check out the new Canadian consensus guidelines:https://doi.org/10.1177/1715163520949973

What do we know about the role of PDGF signaling in neurodegenerative disease

Check out our recent review here:https://doi.org/10.20517/2574-1209.2020.16

About

Dr. Michael A. Beazely has been a professor at the School of Pharmacy, University of Waterloo, since it was established in 2008. Our research if focused on the fundamentals of neuronal signaling and substance use education and harm reduction.

Contact

Michael A. Beazely

Associate Professor

School of Pharmacy, University of Waterloo

10 Victoria Street South

Kitchener, ON, N2G 1C5

519.888.4567 x21310

mbeazely@uwaterloo.ca

http://orcid.org/0000-0002-8722-460X

Michael Beazely 2016